Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sloan

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Cytometry. Part B, Clinical Cytometry|October 1, 2008
Assessment of mitochondrial toxicity by analysis of mitochondrial protein expression in mononuclear cellsChen-Han Lin, Derek D Sloan, Chung H Dang, et al.
Plos One|July 13, 2016
Seasonal Timing of Infant Bronchiolitis, Apnea and Sudden Unexplained Infant DeathChantel D Sloan, Tebeb Gebretsadik, Christian Rosas-Salazar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Inhibition of TCR signaling by herpes simplex virusDerek D Sloan, Jin-Young Han, Tracy K Sandifer, et al.
Toxicological and Environmental Chemistry|November 26, 2013
Indoor and Outdoor Air Pollution and Lung Cancer in New Hampshire and VermontChantel D Sloan, Angeline S Andrew, Joann F Gruber, et al.
AIDS (London, England)|July 22, 2010
HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assaysTamara Bar-Magen, Daniel A Donahue, Emily I McDonough, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral loadVictor G Kramer, Susan M Schader, Maureen Oliveira, et al.
Journal of Virology|February 24, 2017
Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral ReservoirMichael T Hensel, Jason D Marshall, Michael R Dorwart, et al.
The Journal of Allergy and Clinical Immunology|May 24, 2016
Respiratory syncytial virus immunoprophylaxis in high-risk infants and development of childhood asthmaKecia N Carroll, Tebeb Gebretsadik, Gabriel J Escobar, et al.
Endocrinology|December 13, 2005
Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese miceLauren P Shearman, Sheng-Ping Wang, Steffen Helmling, et al.
AIDS (London, England)|January 16, 2018
Blood biomarkers of expressed and inducible HIV-1Anthony R Cillo, Francis Hong, Angela Tsai, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Cytometry. Part B, Clinical Cytometry|October 1, 2008
Assessment of mitochondrial toxicity by analysis of mitochondrial protein expression in mononuclear cellsChen-Han Lin, Derek D Sloan, Chung H Dang, et al.
Plos One|July 13, 2016
Seasonal Timing of Infant Bronchiolitis, Apnea and Sudden Unexplained Infant DeathChantel D Sloan, Tebeb Gebretsadik, Christian Rosas-Salazar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Inhibition of TCR signaling by herpes simplex virusDerek D Sloan, Jin-Young Han, Tracy K Sandifer, et al.
Toxicological and Environmental Chemistry|November 26, 2013
Indoor and Outdoor Air Pollution and Lung Cancer in New Hampshire and VermontChantel D Sloan, Angeline S Andrew, Joann F Gruber, et al.
AIDS (London, England)|July 22, 2010
HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assaysTamara Bar-Magen, Daniel A Donahue, Emily I McDonough, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral loadVictor G Kramer, Susan M Schader, Maureen Oliveira, et al.
Journal of Virology|February 24, 2017
Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral ReservoirMichael T Hensel, Jason D Marshall, Michael R Dorwart, et al.
The Journal of Allergy and Clinical Immunology|May 24, 2016
Respiratory syncytial virus immunoprophylaxis in high-risk infants and development of childhood asthmaKecia N Carroll, Tebeb Gebretsadik, Gabriel J Escobar, et al.
Endocrinology|December 13, 2005
Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese miceLauren P Shearman, Sheng-Ping Wang, Steffen Helmling, et al.
AIDS (London, England)|January 16, 2018
Blood biomarkers of expressed and inducible HIV-1Anthony R Cillo, Francis Hong, Angela Tsai, et al.
Pageof 19